Blast Phase Chronic Myelogenous Leukemia Bcr-abl1-positive

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia [Phase 2]

  Phase 2 clinical trial evaluating decitabine, venetoclax, and ponatinib for Philadelphia chromosome-positive acute myeloid leukemia and rela…

• CLINICAL_TRIALS trial_result · 2023-07-17
  Clinical Trial Update: Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML [Phase 1, Phase 2]

  Phase I/II study evaluating bosutinib combined with inotuzumab ozogamicin in CD22-positive ALL and CML showed completed status with results …

• CLINICAL_TRIALS trial_result · 2023-02-01
  Clinical Trial Update: Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy [Phase 2, Phase 3]

  Clinical trial updates for eltrombopag olamine in thrombocytopenia associated with chronic myeloid leukemia or myelofibrosis during tyrosine…

• CLINICAL_TRIALS trial_result · 2017-03-10
  Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating donor lymphocyte infusion for patients with persistent, relapsed, or progressing cancer after donor hema…